Mirtazapine

Chemical formula: C₁₇H₁₉N₃  Molecular mass: 265.353 g/mol  PubChem compound: 4205

Active ingredient description

Mirtazapine is a centrally active presynaptic α2-antagonist, which increases central noradrenergic and serotonergic neurotransmission. The enhancement of serotonergic neurotransmission is specifically mediated via 5-HT1 receptors, because 5-HT2 and 5-HT3 receptors are blocked by mirtazapine. Both enantiomers of mirtazapine are presumed to contribute to the antidepressant activity, the S(+) enantiomer by blocking α2 and 5-HT2 receptors and the R(-) enantiomer by blocking 5-HT3 receptors.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N06AX11 Mirtazapine N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX11

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
MIRTAZAPINE Orodispersible tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
REMERON Tablet / Orally disintegrating tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 61337-67-5
CAS Substance: 85650-52-8
DrugBank Drug: DB00370
KEGG Drug: D00563
PubChem Compound: 4205
RxNorm Ingredient: 15996
SNOMED-CT Concept: 386847004
Mirtazapine (substance)
UNII Identifier: A051Q2099Q
MIRTAZAPINE

Medicines

Mirtazapine is an active ingredient of these brands:

United States (US)

Austria (AT)

Canada (CA)

Croatia (HR)

Cyprus (CY)

France (FR)

Germany (DE)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Malta (MT)

Mexico (MX)

Netherlands (NL)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.